urologic debate part 2: mri vs. molecular markers: which one should i use? markers perspective
Published 3 years ago • 292 plays • Length 11:39Download video MP4
Download video MP3
Similar videos
-
14:24
urologic debate part 1: mri vs. molecular markers: which one should i use? mri perspective
-
14:05
integrating mri and molecular markers to detect aggressive prostate cancer
-
13:31
diagnosing renal masses: do advanced imaging techniques and biomarkers play an important role?
-
10:20
current clinical utility of mri and multi-modality imaging
-
10:55
point counterpoint: mri
-
43:01
to the point: focal or definitive therapy for prostate cancer: mri vs. mapping part ii
-
4:34
the fear of cancer & choosing active surveillance | ask a prostate expert, mark scholz, md
-
21:50
use of germline and somatic molecular testing in prostate cancer diagnosis
-
29:11
tale of two tumors: wilms tumor management | urology grand rounds
-
26:20
mapping pathology as a guide to focal therapy the role of mapping biopsies and tissue markers
-
13:48
high resolution micro-ultrasound vs. mri for staging and diagnosis
-
6:43
in my opinion: biomarkers for the diagnosis of prostate cancer
-
28:33
active surveillance results and implications of prospective studies
-
22:54
to the point: focal or definitive therapy for prostate cancer: mri vs. mapping part i
-
17:36
forward progress in molecular markers for prostate cancer
-
15:42
urinary markers in bladder cancer
-
43:48
urinary molecular marker tests in bladder cancer: an overview of cxbladder
-
1:59
how mri helps you get a more accurate prostate biopsy
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
2:31
an mri-based approach to prostate cancer diagnosis: a urologist’s stance in the debate
-
10:03
multi-modality (mri pet) imaging for improved detection of cspc
-
14:48
urinary markers in nmibc what's new youtube